News & Insights

Discover the latest updates on our company and investments in life science

Sciety news

Implementation of AI in healthcare gains momentum

INSIGHT. The rapid advancement of artificial intelligence is expected to significantly transform healthcare, and implementation is gaining momentum. In a survey conducted by McKinsey earlier this year, more than 70% of participants, consisting of representatives from various healthcare organisations, indicated that they have either already implemented or are in the

Read More »

Sciety 10 years: From idea to leading investment company

NEWS. When Sciety was founded in 2014, the vision was clear – to bridge the gap between scientific breakthroughs and societal benefit. Ten years later, we have grown to become one of the Nordic region’s leading investors in life science and digital health, with over one billion SEK invested in

Read More »

CDMOs are taking a more central role in the pharmaceutical industry

INSIGHT. In the pharmaceutical industry, contract development and manufacturing organizations (CDMOs) have taken on an increasingly central role. Over the past decade, these companies have shifted from being mere manufacturing partners to becoming drivers of innovation and technological development. To meet the changing demands of the pharmaceutical industry and the

Read More »

The future of healthcare – innovations in diagnostics and treatment

INSIGHT. We find ourselves in a time when groundbreaking technologies such as artificial intelligence, next-generation DNA sequencing, and data-driven precision medicine rapidly reshape the healthcare landscape. The market for AI in healthcare is projected to exceed 100 billion dollars by 2028, with an annual growth rate of over 47% compared

Read More »

The rise of peptide-based pharmaceuticals

INSIGHT. Peptides (short chains of amino acids) have long been used in the development of pharmaceuticals, such as diabetes medicine. In recent years, we’ve seen a dramatic increase in peptide-based pharmaceuticals.  In 2022, peptide pharmaceuticals accounted for 5 percent of the global pharmaceutical market, with a market value of USD

Read More »

From idea to impact – creating innovations that save lives

INSIGHT. Medical advancements that save or improve the lives of others often start in the lab, initiated and driven by the curiosity and determination of individual researchers or research teams. In Sweden, renowned for its exceptional universities, researchers have extensive opportunities to transition their discoveries from the lab to the market,

Read More »